EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway

Xiaojun Ouyang iD, Zhiyuan Long iD, Xiaodan Xu iD, Mengjie Jiang iD, Yuxin Pei iD, Bei Jin iD, Cheng Cheng iD, Hongjie Zhuang iD, Yifang Gao iD, Tinghuai Wang iD, Xiaoyun Jiang iD

Clinical Science · 12.08.2026 · 140 (8) · 1695-1708

DOI: 10.1042/cs20261084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 16.07.2026. Verfasst von Xiaojun Ouyang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Nephrology and Rheumatology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510030, China. Hauptthemen laut MEDLINE: Thymosin, Acute Kidney Injury, Sepsis, MAP Kinase Signaling System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), MOST | National Key Research and Development Program of China (NKPs), Guangdong Weiji Medical Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis-associated acute kidney injury (SA-AKI) is a common complication in septic patients and is associated with high mortality and progression to chronic kidney disease. Previous studies have demonstrated that thymosin β4 (Tβ4) attenuates lipopolysaccharide (LPS)-induced liver injury and ischemic AKI by suppressing inflammatory responses. Here, we aimed to investigate the effects of Tβ4 on SA-AKI and elucidate its underlying mechanisms. In vivo and in vitro models of SA-AKI were established using LPS. Tβ4 was administered 30 min after LPS exposure. Transcriptome sequencing was performed to explore the underlying molecular mechanisms, followed by validation using western blotting and qRT-PCR. In SA-AKI mice, serum Tβ4 levels were significantly decreased. Administration of Tβ4 ameliorated renal dysfunction and morphological injury in LPS-treated mice, accompanied by reduced renal inflammation and apoptosis. Transcriptome-sequencing analysis indicated that the MAPK signaling pathway was involved in both SA-AKI pathogenesis and the protective effect of Tβ4. Western blotting of the renal tissues confirmed that LPS enhanced the phosphorylation of JNK1/2, p38 MAPK, and ERK1/2, while Tβ4 significantly suppressed their activation. In HK-2 cells, pharmacological activation of the MAPK pathway with anisomycin restored MAPK phosphorylation and partially reversed the inhibitory effects of Tβ4 on the mRNA expression of the pro-inflammatory cytokines IL-6, IL-1β, and IL-18. In conclusion, Tβ4 alleviates renal inflammation and apoptosis in SA-AKI by suppressing the MAPK signaling pathway. Tβ4 may represent a potential therapeutic strategy for early intervention in SA-AKI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThymosinAcute Kidney InjurySepsisMAP Kinase Signaling SystemAnimalsThymosin beta(4)MaleHumansApoptosisLipopolysaccharidesDisease Models, AnimalCell LineMice, Inbred C57BLMiceKidney

Stichwörter der Autor:innen

acute kidney injurymitogen-activated protein kinasessepsisthymosin β4

Substanzen

ThymosinThymosin beta(4)Lipopolysaccharides

Autor:innen und Institutionen

  • Department of Pediatric Nephrology and Rheumatology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510030, China.
  • Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510030, China.
  • Department of Physiology, School of Basic Medical Sciences, Southwest Medical University, Lu Zhou, China.
  • Department of Physiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510030, China.
  • Organ Transplantation Center, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510030, China.

ORCID-Profile: Xiaojun Ouyang, Zhiyuan Long, Xiaodan Xu, Mengjie Jiang, Yuxin Pei, Bei Jin, Cheng Cheng, Hongjie Zhuang, Yifang Gao, Tinghuai Wang, Xiaoyun Jiang

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • MOST | National Key Research and Development Program of China (NKPs)
  • Guangdong Weiji Medical Development Foundation
  • College Student Innovation and Entrepreneurship Program of Sun Yat-sen University

Zitieren

APA

Ouyang, X., Long, Z., Xu, X., Jiang, M., Pei, Y., Jin, B., Cheng, C., Zhuang, H., Gao, Y., Wang, T., & Jiang, X. (2026). Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway. Clinical Science, 140(8), 1695-1708. https://doi.org/10.1042/cs20261084

Vancouver

Ouyang X, Long Z, Xu X, Jiang M, Pei Y, Jin B, et al. Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway. Clinical Science. 2026;140(8):1695-1708. doi:10.1042/cs20261084

BibTeX
@article{Ouyang2026,
  author = {Ouyang, Xiaojun and Long, Zhiyuan and Xu, Xiaodan and Jiang, Mengjie and Pei, Yuxin and Jin, Bei and Cheng, Cheng and Zhuang, Hongjie and Gao, Yifang and Wang, Tinghuai and Jiang, Xiaoyun},
  title = {Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway},
  journal = {Clinical Science},
  year = {2026},
  volume = {140},
  number = {8},
  pages = {1695--1708},
  doi = {10.1042/cs20261084}
}
Kostenlos starten →